trial · primary record
Terbinafine
Recurrent Prostate Cancer
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 42 |
| Primary completion | 2030-10 |
| Primary endpoint | Prostate specific antigen Progression-free rate (PSA-PFR) |
| Registry ID | NCT07365423 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T13:41:50.303Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07365423
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.